Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$3.74M
13.60K shares
What this filing means
HAAS JASON plans to sell 13.60K shares of LIGAND PHARMACEUTICALS INC valued at approximately $3.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2026ACC: 0001950047-26-008011
13.60K
Shares to sell
$3.74M
Approx. market value
7.14K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
8/12/2026
3.38KStock Option Exercise
Cash
8/12/2026
2.76KRestricted Stock
Not Applicable
6/29/2025
1KTotal acquired7.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2026 | Stock Option Exercise Cash | 3.38K | — |
8/12/2026 | Stock Option Exercise Cash | 2.76K | — |
6/29/2025 | Restricted Stock Not Applicable | 1K | — |
| Total | 7.14K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.46K
Market value
$1.65M
6/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.14K
Market value
$2.09M
8/12/2026
Total
Units
13.60K
Value
$3.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/12/2026 | 6.46K | $1.65M | — | Completed |
| Planned — Approximate Date | ||||
8/12/2026 | 7.14K | $2.09M | NASDAQ | Planned |
| Total | 13.60K | $3.74M | ||